ATRACURIUM BESYLATE
Generic: ATRACURIUM BESYLATE
HospiraManufacturer
INTRAVENOUSRoute
ATRACURIUM BESYLATEActive Substance
2012-10-18Original Approval
ATRACURIUM BESYLATE is FDA application ANDA090761, sponsored by HOSPIRA INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
HYPOTENSION
74 reports
2
ANAPHYLACTIC REACTION
66 reports
3
ANAPHYLACTIC SHOCK
66 reports
4
BRADYCARDIA
40 reports
5
BRONCHOSPASM
35 reports
6
DRUG INTERACTION
35 reports
7
CARDIAC ARREST
33 reports
8
THROMBOCYTOPENIA
30 reports
9
DRUG INEFFECTIVE
26 reports
10
OXYGEN SATURATION DECREASED
26 reports